BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2516866)

  • 1. Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.
    Ohashi Y; Awata T; Sogo S; Ohira M; Matsuda M; Fukuda M; Manabe R
    J Ocul Pharmacol; 1989; 5(4):325-8. PubMed ID: 2516866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.
    Awata T; Sogo S; Yamagami Y; Yamamoto Y
    J Ocul Pharmacol; 1988; 4(3):195-201. PubMed ID: 3143793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
    Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal permeability of aldose reductase inhibitor, M79175. II. In vivo study on pharmacokinetic aspect.
    Kato A; Horie T; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):287-94. PubMed ID: 3139809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The intraocular penetration of ARI (M-79175) in rabbit eyes].
    Kojima M; Sasaki K; Taniguchi T
    Nippon Ganka Gakkai Zasshi; 1987 Jun; 91(6):643-6. PubMed ID: 3120520
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the aldose reductase inhibitor imirestat following topical ocular administration.
    Brazzell RK; Wooldridge CB; Hackett RB; McCue BA
    Pharm Res; 1990 Feb; 7(2):192-8. PubMed ID: 2106677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of aldose reductase inhibitor concentrations in the lens and inhibitory effect on sugar alcohol accumulation.
    Yamamoto Y; Ohtori A
    Curr Eye Res; 1990 May; 9(5):421-8. PubMed ID: 2116955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
    Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
    Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.
    Kato A; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):279-86. PubMed ID: 3139808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration.
    Song JS; Kim JH; Yang M; Sul D; Kim HM
    Cornea; 2006 Dec; 25(10 Suppl 1):S20-3. PubMed ID: 17001187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
    Crabbe MJ; Petchey M; Burgess SE; Cheng H
    Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.
    Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R
    Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
    Hosotani H; Ohashi Y; Yamada M; Tsubota K
    Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aldose reductase inhibitor on the corneal epithelium.
    Tsubota K; Yamada M
    Cornea; 1993 Mar; 12(2):161-2. PubMed ID: 8500324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular penetration of ketoconazole in rabbits.
    Hemady RK; Chu W; Foster CS
    Cornea; 1992 Jul; 11(4):329-33. PubMed ID: 1424654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium activity in the aqueous humor and corneal stroma of the rabbit.
    Stiemke MM; Roman RJ; Palmer ML; Edelhauser HF
    Exp Eye Res; 1992 Sep; 55(3):425-33. PubMed ID: 1330666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.